Advanced Search

 

Study ID Status Title Patient Level Data
116571 Completed A 12-week randomised, double-blind, parallel-group study to evaluate the anti-inflammatory effects of ADOAIR® 50/250mcg twice daily compared with placebo twice daily in Japanese subjects with chronic obstructive pulmonary disease (COPD)
116572 Completed A randomised, double-blind, double dummy, 3 way cross-over study evaluating the effects of ADOAIR 50/250mcg twice daily plus tiotropium bromide 18mcg once daily compared with the individual treatments (tiotropium bromide 18mcg alone and ADOAIR 50/250mcg alone) in the treatment of Japanese subjects with COPD Study Listed on ClinicalStudyDataRequest.com
116576 Completed A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
116581 Completed A four-week Phase IIa, randomized, double-blind, placebo-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of GSK1278863 in subjects with anemia associated with chronic kidney disease who are not taking recombinant human erythropoietin and are not undergoing dialysis Study Listed on ClinicalStudyDataRequest.com
116582 Completed A four-week, Phase IIa, randomized, active-controlled, parallel-group, multi-center study to evaluate the safety, efficacy and pharmacokinetics of switching subjects from a stable dose of recombinant human erythropoietin to GSK1278863 in hemodialysis-dependent subjects with anemia associated with chronic kidney disease Study Listed on ClinicalStudyDataRequest.com
116585 Completed A single-center, randomized, open-label, crossover study to assess the relative bioavailability of new formulations of GSK1265744 in healthy adult subjects
116586 Completed A Phase II, Open label, Single arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients with Chronic Lymphocytic Leukemia
116592 Completed A randomized, double-blind, placebo-controlled cross-over study to determine the bronchodilator effect of a single dose of fluticasone furoate (FF)/ vilanterol (VI) 100/25 mcg combination administered in the morning in adult patients with asthma Study Listed on ClinicalStudyDataRequest.com
116595 Completed A Single Dose, Open Label, Randomized, Balanced, Crossover Study to Assess the Relative Bioavailability of ThreeFormulations and Food Effect on GSK1322322 in Healthy Subjects Study Listed on ClinicalStudyDataRequest.com
116601 Completed A Randomised, Double-Blind, Placebo-Controlled, Cross-Over, Single-Centre Study to Investigate the Acute Lung Deflation Effects of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg Once Daily on Cardiac Biventricular Function and Arterial Stiffness in Adults with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
116602 Completed Risk of solid organ transplant rejection following vaccination with Pandemrix™ in the United Kingdom
116604 Active, Not Recruiting PGx6039 PGx Investigation of Pyrexia in Subjects Receiving GSK2118436 Monotherapy
116610 Completed An Open Label, Single Center, Adaptive Phase I Study in Healthy Volunteers, to Evaluate the Safety, Efficacy and Dose Responses of SB-751689 (ronacaleret; a calcium sensing receptor antagonist)
116615 Completed Bioequivalence Study for an Isotretinoin Pharmaceutical Preparation - capsules. Crossover, randomized, single dose, two treatments, two periods and two sequences with meal (breakfast) study
116617 Completed A Single-Centre, Double-Blind, Placebo Controlled Two Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of GSK2269557 as a Dry Powder in Healthy Subjects who Smoke Cigarettes Study Listed on ClinicalStudyDataRequest.com
116623 Completed A double-blind [sponsor unblinded], randomized, placebo-controlled, staggered-parallel study to investigate the safety, tolerability, and pharmacodynamics of GSK2890457 in healthy volunteers and subjects with type 2 diabetes Study Listed on ClinicalStudyDataRequest.com
116626 Completed PGx364: An ADME pharmacogenetic investigation to evaluate the pharmacokinetic variability of GSK2190915 in subjects from Studies LPA111834, LPA112025, and LPA112356
116628 Completed A Single Center Phase 1 Double Blind Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
116635 Completed Genetic and phenotypic susceptibility analysis of influenza viruses isolated from hospitalised adult subjects treated with intravenous zanamivir in the phase II study NAI113678
116637 Completed PGx: Exploratory meta-analysis of transcriptomics data from the SB681323 and prednisolone single dose biomarker study in COPD patients
116640 Completed Development of read-outs to detect and characterise the early and adaptive immune responses in healthy, hepatitis B virus naive adults vaccinated with the hepatitis B surface antigen in combination with a GSK Biologicals’ Adjuvant System
116647 Completed An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of GSK Biologicals’ Non-typeable Haemophilus influenzae (NTHi) investigational vaccine (GSK2838497A) in current and former smokers
116663 Completed A Phase III study for evaluation of immunogenicity and reactogenicity of Fluarix/Influsplit SSW 2012/2013 in people aged 18 years and above
116664 Completed Immunogenicity and safety study of GSK Biologicals’ Trivalent Split Virion Influenza Vaccine (GSK1536489A) Fluviral® (2012/2013 Season) in adults aged 18 years and older Study Listed on ClinicalStudyDataRequest.com
116666 Completed An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666) Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.